Drug recall D-0097-2018
Product
Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Goa 403 722 India, NDC 68180-295-06, UPC 368180295068
Reason for recall
Failed Dissolution Specification
Lots and codes
Lot #: G602051, Exp. 12/2017
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 111,648 units
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 21, 2017
- Terminated
- April 15, 2019
Related products
- Duloxetine – drug information
- NDC 68180-295 Duloxetine · Duloxetine Hydrochloride 30 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-297 Duloxetine · Duloxetine Hydrochloride 40 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-296 Duloxetine · Duloxetine Hydrochloride 60 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-294 Duloxetine · Duloxetine Hydrochloride 20 mg/1 · Lupin Pharmaceuticals, Inc.